Global Implantable Drug-Eluting Devices Sales Market Report 2021

1 Implantable Drug-Eluting Devices Market Overview

• 1.1 Implantable Drug-Eluting Devices Product Scope
• 1.2 Implantable Drug-Eluting Devices Segment by Type
  • 1.2.1 Global Implantable Drug-Eluting Devices Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Implantable Drug Infusion Pumps
  • 1.2.3 Intraocular Drug-Eluting Devices
  • 1.2.4 Contraceptive Drug-Eluting Devices
  • 1.2.5 Drug-Eluting Stents
  • 1.2.6 Others
• 1.3 Implantable Drug-Eluting Devices Segment by Application
  • 1.3.1 Global Implantable Drug-Eluting Devices Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Diabetes
  • 1.3.3 Contraception
  • 1.3.4 HIV/AIDS Prevention
  • 1.3.5 Chronic Pain Management
  • 1.3.6 Cardiovascular
  • 1.3.7 Ophthalmology
  • 1.3.8 Oncology
  • 1.3.9 Others
• 1.4 Implantable Drug-Eluting Devices Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Implantable Drug-Eluting Devices Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Implantable Drug-Eluting Devices Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Implantable Drug-Eluting Devices Price Trends (2016-2027)

2 Implantable Drug-Eluting Devices Estimates and Forecasts by Region

• 2.1 Global Implantable Drug-Eluting Devices Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Implantable Drug-Eluting Devices Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
• 2.3 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Implantable Drug-Eluting Devices Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.2 Europe Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.3 China Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.4 Japan Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)
  • 2.4.6 India Implantable Drug-Eluting Devices Estimates and Projections (2016-2027)

3 Global Implantable Drug-Eluting Devices Competition Landscape by Players

• 3.1 Global Top Implantable Drug-Eluting Devices Players by Sales (2016-2021)
• 3.2 Global Top Implantable Drug-Eluting Devices Players by Revenue (2016-2021)
• 3.3 Global Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Drug-Eluting Devices as of 2020)
• 3.4 Global Implantable Drug-Eluting Devices Average Price by Company (2016-2021)
• 3.5 Manufacturers Implantable Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Implantable Drug-Eluting Devices Market Size by Type

• 4.1 Global Implantable Drug-Eluting Devices Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2021)
• 4.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Type (2022-2027)

5 Global Implantable Drug-Eluting Devices Market Size by Application

• 5.1 Global Implantable Drug-Eluting Devices Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Implantable Drug-Eluting Devices Price by Application (2016-2021)
• 5.2 Global Implantable Drug-Eluting Devices Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Implantable Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 North America Implantable Drug-Eluting Devices Market Facts & Figures

• 6.1 North America Implantable Drug-Eluting Devices Sales by Company
  • 6.1.1 North America Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 6.1.2 North America Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 6.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 6.2.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 6.3 North America Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 6.3.1 North America Implantable Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Implantable Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

7 Europe Implantable Drug-Eluting Devices Market Facts & Figures

• 7.1 Europe Implantable Drug-Eluting Devices Sales by Company
  • 7.1.1 Europe Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 7.1.2 Europe Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 7.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 7.2.1 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 7.3 Europe Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China Implantable Drug-Eluting Devices Market Facts & Figures

• 8.1 China Implantable Drug-Eluting Devices Sales by Company
  • 8.1.1 China Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 8.1.2 China Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 8.2 China Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 8.2.1 China Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 8.3 China Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 8.3.1 China 311 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Implantable Drug-Eluting Devices Market Facts & Figures

• 9.1 Japan Implantable Drug-Eluting Devices Sales by Company
  • 9.1.1 Japan Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 9.1.2 Japan Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 9.2 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 9.2.1 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 9.3 Japan Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Implantable Drug-Eluting Devices Market Facts & Figures

• 10.1 Southeast Asia Implantable Drug-Eluting Devices Sales by Company
  • 10.1.1 Southeast Asia Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 10.2 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 10.2.1 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Implantable Drug-Eluting Devices Market Facts & Figures

• 11.1 India Implantable Drug-Eluting Devices Sales by Company
  • 11.1.1 India Implantable Drug-Eluting Devices Sales by Company (2016-2021)
  • 11.1.2 India Implantable Drug-Eluting Devices Revenue by Company (2016-2021)
• 11.2 India Implantable Drug-Eluting Devices Sales Breakdown by Type
  • 11.2.1 India Implantable Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Implantable Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
• 11.3 India Implantable Drug-Eluting Devices Sales Breakdown by Application
  • 11.3.1 India Implantable Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Implantable Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Implantable Drug-Eluting Devices Business

• 12.1 Pfizer
  • 12.1.1 Pfizer Corporation Information
  • 12.1.2 Pfizer Business Overview
  • 12.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
  • 12.1.5 Pfizer Recent Development
• 12.2 Medtronic
  • 12.2.1 Medtronic Corporation Information
  • 12.2.2 Medtronic Business Overview
  • 12.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
  • 12.2.5 Medtronic Recent Development
• 12.3 Merck
  • 12.3.1 Merck Corporation Information
  • 12.3.2 Merck Business Overview
  • 12.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Merck Implantable Drug-Eluting Devices Products Offered
  • 12.3.5 Merck Recent Development
• 12.4 Bayer AG
  • 12.4.1 Bayer AG Corporation Information
  • 12.4.2 Bayer AG Business Overview
  • 12.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
  • 12.4.5 Bayer AG Recent Development
• 12.5 Johnson & Johnson
  • 12.5.1 Johnson & Johnson Corporation Information
  • 12.5.2 Johnson & Johnson Business Overview
  • 12.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
  • 12.5.5 Johnson & Johnson Recent Development
• 12.6 Abbott
  • 12.6.1 Abbott Corporation Information
  • 12.6.2 Abbott Business Overview
  • 12.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
  • 12.6.5 Abbott Recent Development
• 12.7 Surmodics
  • 12.7.1 Surmodics Corporation Information
  • 12.7.2 Surmodics Business Overview
  • 12.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
  • 12.7.5 Surmodics Recent Development
• 12.8 Boston Scientific Corporation
  • 12.8.1 Boston Scientific Corporation Corporation Information
  • 12.8.2 Boston Scientific Corporation Business Overview
  • 12.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
  • 12.8.5 Boston Scientific Corporation Recent Development
• 12.9 Titan Pharmaceuticals, Inc.
  • 12.9.1 Titan Pharmaceuticals, Inc. Corporation Information
  • 12.9.2 Titan Pharmaceuticals, Inc. Business Overview
  • 12.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
  • 12.9.5 Titan Pharmaceuticals, Inc. Recent Development
• 12.10 BIOTRONIK
  • 12.10.1 BIOTRONIK Corporation Information
  • 12.10.2 BIOTRONIK Business Overview
  • 12.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
  • 12.10.5 BIOTRONIK Recent Development
• 12.11 Allergan
  • 12.11.1 Allergan Corporation Information
  • 12.11.2 Allergan Business Overview
  • 12.11.3 Allergan Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Allergan Implantable Drug-Eluting Devices Products Offered
  • 12.11.5 Allergan Recent Development
• 12.12 Bausch & Lomb
  • 12.12.1 Bausch & Lomb Corporation Information
  • 12.12.2 Bausch & Lomb Business Overview
  • 12.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Products Offered
  • 12.12.5 Bausch & Lomb Recent Development
• 12.13 REVA Medical
  • 12.13.1 REVA Medical Corporation Information
  • 12.13.2 REVA Medical Business Overview
  • 12.13.3 REVA Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 REVA Medical Implantable Drug-Eluting Devices Products Offered
  • 12.13.5 REVA Medical Recent Development
• 12.14 MicroPort Medical
  • 12.14.1 MicroPort Medical Corporation Information
  • 12.14.2 MicroPort Medical Business Overview
  • 12.14.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 MicroPort Medical Implantable Drug-Eluting Devices Products Offered
  • 12.14.5 MicroPort Medical Recent Development

13 Implantable Drug-Eluting Devices Manufacturing Cost Analysis

• 13.1 Implantable Drug-Eluting Devices Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Implantable Drug-Eluting Devices
• 13.4 Implantable Drug-Eluting Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Implantable Drug-Eluting Devices Distributors List
• 14.3 Implantable Drug-Eluting Devices Customers

15 Market Dynamics

• 15.1 Implantable Drug-Eluting Devices Market Trends
• 15.2 Implantable Drug-Eluting Devices Drivers
• 15.3 Implantable Drug-Eluting Devices Market Challenges
• 15.4 Implantable Drug-Eluting Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List